JPRN-UMIN000038467已完成未知
Proteomic analysis for establishing a biomarker panel for the onset of Adult T-cell Leukemia (ATL) - Proteomic analysis for establishing a biomarker panel for AT
niversity of the Ryukyus0 个研究点目标入组 85 人开始时间: 2020年3月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 85
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Participants withdrawing consent through opt-out forms available online at the homepage of the Laboratory of Hematoimmunology are excluded
研究者
相似试验
尚未招募
不适用
Application of proteomics to aid biomarker discovery in smear positive patients of P.vivax and P.falciparum malariaCTRI/2010/091/000451Department of Biosciences and Bioengineering, Indian Institute of Technology (IIT), Powai, Mumbai- 400 076100
进行中（未招募）
不适用
Evaluación mediante proteómica de biomarcadores proteicos asociados con el tratamiento con Eplerenona versus espironolactona en pacientes post-infarto agudo de miocardio, diabéticos con hipertensión arterial no controlada y disfunción ventricular sistólica leve”Identification of proteomic biomarkers associated with eplerenone treatment versus spironolactone in post-acute coronary syndrome patients, with non-controlled arterial hypertension and ventricular dysfunction - PROMETEODisfunción ventricular leve-moderada post-infarto agudo de miocardio en pacientes diabéticos con hipertensión arterial no controlada.Low-moderate ventricular dysfunction in post-acute coronary syndrome patients with diabetes and non-controlled arterial hypertension.EUCTR2008-001192-29-ESFundación Investigación y Desarrollo en el Area Cardiovascular
进行中（未招募）
不适用
Identificación de biomarcadores proteicos asociados a resistencia a la aspirina y a tienopiridinas en pacientes con cardiopatía isquémica establecida. (ESTUDIO BIRAT).Identification of new protein biomarkers associated with aspirin and thienopyridine resistance in stable coronary ischaemic patients: a proteomic study. (BIRAT Study). - BIRATEUCTR2007-006686-32-ESFUNDACIÓN INVESTIGACIÓN BIOMEDICA DEL HOSPITAL CLINICO SAN CARLOS
招募中
不适用
Candidate biomarker analysis in proteomics of vessel & fat tissue from patients with coronary artery bypass graft (Proteomics research center for metabolic disease)Diseases of the circulatory systemKCT0000465Seoul National University Bundang Hospital25
进行中（未招募）
不适用
Proteomic profile analysis to classify advanced pancreatic adenocarcinoma patients for clinical outcome after treatment with PDXG (cisplatin, docetaxel, capecitabine, gemcitabine) or PEXG (cisplatin, epirubicin, capecitabine, gemcitabine) regimen. - NDpatients affected by adenocarcinoma at stage III or IV who are candidate to receive upfront chemotherapy according to PDXG or PEXG regimen.MedDRA version: 9.1Level: LLTClassification code 10052747Term: Adenocarcinoma pancreasEUCTR2009-013029-41-ITFONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR